Peptides that bind to the erythropoietin receptor

Details for Australian Patent Application No. 2004238868 (hide)

Owner Affymax, Inc.

Inventors Balu, Palani; Lalonde, Guy; Holmes, Christopher; Schatz, Peter J.; Yin, Kevin; Tumelty, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004238868

PCT Pub. Number WO2004/101611

Priority 60/470,245 12.05.03 US

Filing date 12 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 21 January 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/101611 Priority application(s): WO2004/101611

21 January 2010 Application Accepted

  Published as AU-B-2004238868

20 May 2010 Standard Patent Sealed

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238869-Novel poly(ethylene glycol) modified compounds and uses thereof

2004238859-Preparation of and dispensing chlorine dioxide